The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has announced plans to expand its operations across the National Capital Region (NCR) to provide quality cancer treatment to more people.
Read MoreIt is with deep sadness that we announce the passing of Dr Sandip Chatterjee, one of India’s most esteemed neurosurgeons, and a remarkable human being
Read MoreMumbai-based ENTOD Pharmaceuticals is working with the Drug Controller General of India (DCGI) to address concerns over its recently approved Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25per cent w/v, branded as PresVu eye drops. Approved on August 6 for the treatment of presbyopia in adults, the drug's approval was suspended by DCGI on September 10 after healthcare professionals raised concerns.
Read MoreThe report examined 99,492 samples from public and private healthcare facilities across the country. These samples, collected from areas such as the blood, urine, and respiratory tract, were tested against bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus.
Read MoreAccording to the GLOBOCAN 2022 data, lung cancer is the fourth leading cause of cancer-related mortality in India. NSCLC accounts for a significant proportion of these cases, with about 15 per cent of patients having resectable disease, this data underscores the importance of targeted treatment options.
Read MoreThe Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies.
Read MoreAster DM Healthcare has announced plans to launch the largest Women & Children’s Hospital in Hyderabad. The state-of-the-art facility, spanning 3 lakh square feet, will feature 300 beds and offer advanced care for women and children.
Read MoreBajaj Healthcare entered a new development and supply agreement with a European partner for an Active Pharmaceutical Ingredient (API).
Read MoreIndian Immunologicals Limited (IIL), has signed a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of India’s first codon de-optimised live attenuated Zika vaccine.
Read More